Hair growth can range from barely noticeable to extraordinary extremes. While some experience hair loss, others live with hypertrichosis, a rare condition characterized by excessive hair growth across the body or in specific areas.
Throughout history, people with hypertrichosis were often displayed as circus or sideshow performers, reflecting the stigma and exploitation they could face because of their appearance.1 They were given labels such as “dog-faced man” and “bearded woman,” while the condition later became popularly known as “werewolf syndrome”—a sensationalized term that can obscure the real people living with it.
While other people stigmatized the condition, scientists asked one question: Could studying conditions characterized by excessive hair growth reveal new ways to understand and regulate hair growth in humans? Today, researchers are investigating the genetic and molecular mechanisms underlying these conditions, hoping to uncover potential therapeutic targets for developing new treatments that regulate hair growth.
Getting to the Root of Hair Loss and Growth
Ting Chen, a stem cell biologist at the National Institute of Biological Sciences, does just that. Her research initially focused on how stem cells drive hair follicle regeneration in mice, but a familiar question began to challenge her perspective. People would often approach her with the same question: “You work on skin and hair follicles. What can you do about my hair loss?”
At the time, her answer was simple: nothing. She knew more about mouse hair than human scalp hair. In mice, a growth phase may last only a few weeks, whereas human scalp hair can remain in its growth phase for years. Those differences make it difficult to translate findings from mouse studies directly into treatments for human hair loss. But rather than abandoning mouse research, Chen began exploring how mouse and human hair studies could complement one another to better understand hair growth and its implications for treating hair loss.
The challenge extended beyond the differences between species. Chen recognized that hair loss can have many causes, including hormonal changes, genetics, stress, and metabolic disturbances. “We just keep finding ways that hair can be destroyed, and it doesn't mean if we reverse it, hair will grow better. It's just another way this can go bad,” she said.
So, she began to consider the problem from the opposite direction. Instead of asking how hair could be prevented from falling out, what if scientists could discover how to make it grow better in humans? That question led her to hypertrichosis.
What is Hypertrichosis or “Werewolf Syndrome”?
Unlike common forms of hair loss, hypertrichosis offers a rare opportunity to study what happens when the body's hair-growth machinery becomes unusually active. Congenital generalized hypertrichosis terminalis (CGHT), a rare, inherited form of the condition, has provided researchers like Chen with clues about the genetic and molecular mechanisms that regulate human hair growth.
In previous studies, researchers conducted phenotype and genetic mapping among affected and unaffected family members and found that CGHT can result from DNA deletions or inverted duplication, wherein a segment of a chromosome is copied and flipped around on chromosome 17.2 Rather than being caused by a single nucleotide variation, CGHT is driven by regional disruptions.
“[These changes] disrupt the 3D organization of the chromatin that somehow affects the genes around the deleted region,” explained Chen. This region of interacting genes and regulatory elements is known as topologically associating domains (TADs). For TAD disruptions in CGHT, genes related to hair growth can run amok.
Unraveling Chromosome Structure for Genetic Leads
The incidence of CGHT is estimated to be one in a billion, with fewer than 100 documented cases worldwide. Because of its rarity, it took Chen and her colleagues almost four years to find patients and collect samples. To study TAD changes, Chen and her team used high-throughput chromosome conformation capture (Hi-C) analysis of stem cells isolated from blood from five patients with CGHT and healthy control patients.
In the wild type patient controls, the Hi-C analysis identified four major TADs around the mutation site. In comparison, CGHT patient-derived cells exhibited various deletions and inverted duplications within these four TADs. Notably, all five patients exhibited abnormal expression of potassium inwardly rectifying channel subfamily J member 2 (KCNJ2), a gene that encodes a potassium channel involved in regulating a cell’s electrical properties.
“Right away, [that] made total sense to us because the only over-the-counter available drug for hair loss is minoxidil, [or Rogaine]. Minoxidil was discovered as a potassium channel activator,” explained Chen.
The researchers then performed single-cell RNA sequencing on skin biopsies. They found increased KCNJ2 expression in the skin of patients with hypertrichosis, along with elevated expression of genes associated with Wnt signaling and hair follicle development.
To explore how KCNJ2 might influence hair growth, the team studied mouse models engineered to overexpress the gene in different skin cell types, including dermal fibroblasts—the connective-tissue cells that help coordinate hair follicle activity.
How Electrical Signals May Influence Hair Growth
Potassium channels regulate the electrical potential across cell membranes. Changes in this electrical potential can affect intracellular signaling and alter how dermal fibroblasts respond to molecular cues, such as those involved in hair growth. In mouse models, increased KCNJ2 activity hyperpolarized these cells, which the researchers found also coincided with the hair-growth phase. Inducing the opposite effect delayed hair growth, while KCNJ2-mediated hyperpolarization improved growth in mouse models of aging-related hair loss and androgenetic alopecia. Together, these findings highlight that the upregulation of KCNJ2 may influence fibroblast bioelectricity to promote hair growth, suggesting new avenues for treating hair loss.3
Another Powerful Hair-Growth Molecule
Electrical signaling is not the only mechanism that may help explain excessive hair growth.
Chen remarked that with minoxidil, it is unclear what its target protein is. When they examined downstream effects of KCNJ2 and Wnt signaling, they found multiple secreted factors, including several known hair-inducing factors such as R-Spondin 3 (Rspo3) and signal peptide, CUB domain and EGF-like domain-containing protein 3 (Scube3). The latter molecule was previously identified as a potent hair-growth promoter.4 To test their effects, the researchers injected human RSPO3 and SCUBE3 proteins into mice. Both stimulated hair follicle regeneration, while control injections had no effect.
Although there is currently no cure for CGHT, research into its underlying biology may deepen our understanding of hair growth and help identify new treatment possibilities for a range of hair-related conditions.
- Bondeson J, Miles AE. Julia Pastrana, the nondescript: An example of congenital, generalized hypertrichosis terminalis with gingival hyperplasia. Am J Med Genet. 1993;47(2):198-212.
- Sun M, et al. Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia. Am J Hum Genet. 2009;84(6):807-813.
- Chen D, et al. Fibroblast bioelectric signaling drives hair growth. Cell. 2025;188(19):5175-5193.e21.
- Liu Y, et al. Hedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state. Dev Cell. 2022;57(14):1758-1775.e7.


















